Key result
Dedicated in-hospital paths for COVID-positive STEMI patients did not result in significant treatment delays or differences in key time points of care compared to COVID-negative paths.
Why the study?
During the COVID-19 pandemic, experts suggested reconsidering thrombolysis over primary PCI for STEMI patients due to EMS strain, prompting evaluation of a centralized network with dedicated COVID-19 pathways.
Does a dedicated in-hospital path for COVID-19 positive/suspected patients delay key time points of STEMI care compared to COVID-19 negative patients?
Observational (n=30)
No
Does a dedicated in-hospital path for COVID-19 positive/suspected patients delay key time points of STEMI care compared to COVID-19 negative patients?
A centralized emergency medical system with dedicated in-hospital paths for COVID-19 patients allows maintaining primary PCI as the treatment of choice for STEMI without significant delays.
Answers are grounded in this paper and cite their sources.
Supports dedicated COVID paths for timely STEMI care; hypothesis-generating for broader systems.
On March 11th 2020 the World Health Organization declared the pandemic infection of SARS-CoV-2 (COVID-19) and Italy was one of the most affected country. The regional Emergency Medical System (EMS) founded itself facing an exponential increase in hospitalizations with a consequent organizational system crisis. Experts from Cina, UK and US suggested to reconsider thrombolysis as the best treatment in term of balance between time consumption and operators safety for ST-segment elevation myocardial infarction (STEMI) patients respect to primary PCI (pPCI). The system reorganization consisted in a centralization of all the emergency nets: from 55 hospitals with cardiac catheterization laboratories distributed within our region offering a 24/7 service we passed to 13 Hub and 42 Spoke centres. Dedicated in-hospital paths for patients COVID positive or suspected (pCOV+) and COVID negative (pCOV-) were instituted. We analysed all consecutive patients undergoing emergency coronary angiogram from March 14 to April 14, 2020 at San Carlo Hospital in Milan comparing the two different in-hospital paths. We collected 30 STEMI patients. Eighteen patients (60%) were treated in pCOV-, while twelve patients (40%) in pCOV+. No significant differences were found among the two groups regarding key time points of STEMI care and interestingly we didn't find any treatment delay in pCOV+. In conclusion, a focused overhaul of the EMS may allow to maintain pPCI as the treatment of choice for patients and operators.
No takes yet. Share an insight, caveat, or question.
Tumminello et al. (2020) conducted an observational in STEMI (n=30). COVID positive or suspected (pCOV+) in-hospital path vs. COVID negative (pCOV-) in-hospital path was evaluated on Key time points of STEMI care and treatment delay. Dedicated in-hospital paths for COVID-positive STEMI patients did not result in significant treatment delays or differences in key time points of care compared to COVID-negative paths.
Synapse has enriched 10 related papers. Consider them for comparative context: